Biolase, Inc. (BIOLQ) vs DIH Holding US, Inc. (DHAI)
Biolase, Inc. and DIH Holding US, Inc. are both Medical Devices companies. Biolase, Inc. is the larger, with a market value of $2.3M against $1.6M — 1.5× the size. DIH Holding US, Inc. has the higher net margin (−13.8% vs −71.8%) and the higher return on invested capital (0.00% vs −109.5%). Across the 12 metrics below, DIH Holding US, Inc. leads on 8 and Biolase, Inc. on 4.
Valuation
Profitability
| Metric | BIOLQ | DHAI | Medical Devices median |
|---|---|---|---|
| Gross margin | 34.44% | 51.24% | 56.01% |
| Operating margin | (29.37%) | (11.17%) | (15.03%) |
| Net margin | (71.75%) | (13.80%) | (20.40%) |
| Free cash flow margin | (28.55%) | (7.44%) | (7.24%) |
| Return on equity | 1,349.30% | 24.90% | (15.32%) |
| Return on assets | (100.09%) | (27.77%) | (19.72%) |
| Return on invested capital | (109.48%) | 0.00% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack